If you still believe that television news exists to look out for your best interests, you are hopelessly naive. The big networks are going to protect their customers at all costs, and you are not their customers. You are the product. CNN, NBC, ABC, CBS and Fox are all trying to get as many of us watching as possible so that they can deliver millions upon millions of ad impressions to their true customers. Of course the biggest customers of all are in the pharmaceutical industry. According to Adweek, the pharmaceutical industry spent more than 400 million dollars on national television advertising during the month of March alone…
In March, prescription pharmaceutical brands spent an estimated $403.4 million on national TV advertising, according to recently released data from iSpot.tv, the real-time TV measurement company. That’s almost twice as much as the second top-spending category for the month, automakers (est. $216.1 million), and a 16% increase from prescription pharma’s February outlay.
Big Pharma is the giant elephant in the room and nobody else is even close.
If they keep spending like they did in March, they will have spent nearly 5 billion dollars on national television advertising by the end of this year.
And “news programming” is one of the primary areas where they focus that spending…
Examining how Rx brands are prioritizing TV ad spend, news programming is a key area: Combined, the pharma industry spent nearly $15 million advertising during ABC World News Tonight With David Muir in March, generating 986.7 million TV ad impressions. NBC Nightly News With Lester Holt, Good Morning America, CBS Evening News With Norah O’Donnell, Today and CBS Mornings also were in the top ten programs by spend for the industry.
If a certain industry is showering you with millions upon millions of dollars, do you think that you will have an incentive not to do any negative stories about that industry?
Of course.
It is just human nature.
Any news executive that does not take special care to protect the network’s most important customers is not likely to have a job for long.
JD’s manually curated links for God-fearing MAGA patriots
During the 18 months that stretched from the beginning of 2020 to the middle of 2021, the pharmaceutical industry spent more than 2 billion dollars “on ads during primetime cable news”…
Over two billion dollars ($2.2B) were spent on ads during primetime cable news (5 pm until midnight on CNN, Fox News, and MSNBC) and nightly network news programming on ABC, CBS, and NBC between January 1, 2020 and June 30, 2021. Fox News earned the most in advertising ($622M) and CBS earned the least ($205M).
Please pay special attention to that last sentence.
Fox News received more money from Big Pharma during that period than anyone else.
So if any Fox News hosts were to be highly critical of the pharmaceutical industry, that would put hundreds of millions of dollars at risk. But that is precisely what Tucker Carlson did less than a week before he was fired.
He delivered a blistering monologue in which he revealed the truth about the damage that the industry is doing and the influence that it has over the big news networks…
Personally, I believe that this is one of the primary reasons why he was fired.
But executives at Fox News will never, ever admit this.
No matter how popular you are, you simply are not allowed to threaten the gravy train. There is just way too much money at stake.
And according to a study that was recently conducted at the Johns Hopkins Bloomberg School of Public Health, much of the money that is being spent is used to promote drugs “with low added benefit”…
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health found that the share of promotional spending allocated to consumer advertising was on average 14.3 percentage points higher for drugs with low added benefit compared to drugs with high added benefit.
The analysis also revealed that the majority—68 percent or 92 of the 135 drugs included in the analysis—of the top-selling prescription drugs sold in 2020 were rated as offering low added benefit. The U.S. does not currently assess prescription drugs for comparative effectiveness. The researchers based their rating categories on France and Canada’s ratings of the same prescription drugs sold in the U.S., some under different brand names.
In other words, a lot of these drugs aren’t even that beneficial. But that isn’t what matters.
What matters is getting people hooked on these drugs so that the profits keep rolling in.
If you want to get rich, the pharmaceutical industry is a great place to do it.
Just consider the CEO of Moderna. He made nearly 400 million dollars last year…
Stéphane Bancel, chief executive of Moderna, had a good year in 2022, exercising stock options that netted him nearly $393 million. The company decided his pay wasn’t good enough.
The Cambridge, Mass.-based biotech, known for its lifesaving coronavirus vaccine, raised his salary last year by 50 percent to $1.5 million and increased his target cash bonus, according to a March securities filing. Bancel, 50, says he is donating the proceeds of stock sales to charity. He owns stock worth at least $2.8 billion and, as of the end of last year, had additional stock-based compensation valued at $1.7 billion.
Whether their products are good or not, the pharmaceutical industry is always going to get favorable coverage from the big news networks because that is how the game is played.
And our politicians are always going to protect Big Pharma because they desperately want the sweet, sweet campaign donations to keep arriving. So don’t expect anything to change any time soon.
We have become a nation that is teeming with corruption from the very top to the very bottom, and we are on a collision course with national suicide. No house will be able to stand for long if the foundation is rotten to the core.
And thanks to the endless greed of those that are in positions of power, our foundation has been rotten to the core for a long time. But we aren’t supposed to talk about such things, are we? We are just supposed to pretend everything is fine as they systematically extract billions of dollars out of us.
Michael’s new book entitled “End Times” is now available in paperback and for the Kindle on Amazon.com, and you can check out his new Substack newsletter right here.
Article cross-posted from End of the American Dream.
Bypass Big Tech Censors
Safeguarding Your American Dream: Discover the Power of America First Healthcare
In today’s economy, healthcare costs remain one of the biggest threats to financial stability and family security. Americans work hard to build a better life, yet rising medical expenses can quickly erode savings, force tough trade-offs, and even push families toward debt or bankruptcy. Medical bills continue to rank as the leading cause of personal bankruptcy in the United States, with millions facing underinsurance or unexpected out-of-pocket burdens that no one plans for. Many turn to government-run marketplace plans under the Affordable Care Act, hoping for relief, only to discover that what appears affordable on paper often delivers higher long-term costs, limited real protection, and coverage that may not align with personal values or family needs.
America First Healthcare stands out as a private insurance agency dedicated to helping conservatives and families secure better coverage and better rates through customized, values-aligned options. By conducting free insurance reviews, the agency uncovers hidden gaps in existing policies and connects clients with private alternatives that emphasize personal responsibility, small-government principles, and genuine affordability—often delivering up to 20% savings while providing stronger protection for the American Dream.
The allure of marketplace plans is easy to understand: open enrollment periods, premium tax credits for many households, and the promise of “comprehensive” benefits mandated by law. Yet recent data reveals a different reality, especially after the expiration of enhanced premium subsidies at the end of 2025. Enrollment for 2026 dropped by more than one million people compared to the prior year, with many shifting to lower-tier bronze plans to keep monthly premiums manageable.
These plans feature significantly higher deductibles—averaging around $7,500 nationally—and greater cost-sharing requirements. Families who once paid modest amounts after subsidies now face average premium increases of $65 or more per month, even as they accept plans that leave them responsible for thousands in upfront costs before meaningful coverage kicks in.
High deductibles create a dangerous barrier to care. Studies show that people in such plans are less likely to seek timely treatment for chronic conditions, attend preventive screenings, or fill necessary prescriptions. A seemingly minor illness or injury can balloon into major expenses when patients delay care until problems worsen. For a family of four, a single hospitalization, cancer diagnosis, or unexpected surgery can easily exceed the deductible, triggering coinsurance and out-of-pocket maximums that still leave substantial bills. One recent analysis noted that some proposed changes could push family deductibles toward $31,000 in future years, further exposing households to financial risk.
Beyond the numbers, marketplace plans often carry structural limitations. Coverage for certain critical services may include waiting periods or narrower networks that restrict access to preferred doctors and specialists. Preventive care is required to be covered without cost-sharing, but everything else—lab work, imaging, specialist visits, or ongoing treatment—typically waits until the deductible is met. This reactive model contrasts sharply with the proactive, holistic approach many families prefer, especially those focused on wellness, early intervention, and maintaining health to enjoy life rather than merely reacting to illness.
Values alignment represents another growing concern. Government-influenced plans operate within a framework shaped by federal mandates and political priorities that may not reflect conservative principles of limited government, personal freedom, and ethical stewardship. Families who want to direct their healthcare dollars toward providers and benefits that honor traditional values sometimes find marketplace options feel misaligned, forcing a compromise between affordability and conviction.
Private alternatives, by contrast, offer year-round flexibility without the restrictions of open enrollment windows. Independent agents can shop across a wider range of carriers to design plans tailored to specific family needs—whether that means lower deductibles for frequent medical users, broader provider networks, or add-ons that support wellness and preventive services from day one. Clients frequently report more stable premiums that do not automatically escalate each year, along with genuine cost savings once the full picture of deductibles, copays, and coverage depth is considered.
Take the experience of real families who made the switch. Amanda C. shared that her new plan felt “way better” than what she had through the marketplace. Johnny Y. noted his previous coverage kept increasing annually until he found a more stable private option. Sofia S. expressed delight with her plan and began recommending it to others. These stories echo a common theme: when families move beyond one-size-fits-all government marketplaces, they often discover customized protection that better safeguards both health and finances.
Founder Jordan Sarmiento’s own journey underscores the stakes. In 2021, a six-day hospitalization generated a $95,000 bill. Under a well-structured private “Conservative Care Coverage” plan, his out-of-pocket responsibility would have been just $500. That stark difference illustrates how thoughtful planning and private options can prevent a medical event from becoming a financial catastrophe.
Practical steps exist for anyone questioning their current coverage. Start with a no-obligation review of your existing policy to identify gaps—high deductibles, limited critical-care benefits, or escalating premiums. Compare total projected costs (premiums plus potential out-of-pocket expenses) rather than monthly premiums alone. Consider family health history, anticipated needs, and lifestyle priorities. Private agencies can present side-by-side options that include stronger wellness incentives, broader access, and plans built on shared values of self-reliance and freedom.
In an era when healthcare inflation continues to outpace general cost-of-living increases, relying solely on marketplace solutions carries growing risk. Families who proactively explore private alternatives frequently achieve meaningful savings while gaining peace of mind that their coverage truly works when needed most.
America First Healthcare makes this exploration straightforward through its free review process. Families and individuals receive personalized guidance to close coverage holes, reduce unnecessary expenses, and secure plans that align with conservative principles—protecting wallets, health, and the American Dream without government overreach. Many who complete a review discover they can enjoy better benefits for less, often saving up to 20% while gaining the customization and stability that marketplace plans struggle to deliver.
Ultimately, protecting your family’s future requires looking beyond the marketing of “affordable” government options. By understanding the long-term costs hidden in high deductibles, shifting coverage tiers, and values mismatches, Americans can make empowered choices. Private, values-driven insurance offers a smarter path—one that rewards diligence, supports wellness, and delivers real security. For those ready to move beyond the limitations of traditional marketplace plans, a simple review can reveal options designed to serve families, not bureaucracies. The American Dream thrives when individuals and families retain control over their healthcare decisions, and thoughtful private coverage plays a vital role in making that possible.